These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24300751)

  • 41. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.
    Vazquez Roque MI; Camilleri M; Clark MM; Tepoel DA; Jensen MD; Graszer KM; Kalsy SA; Burton DD; Baxter KL; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):829-37. PubMed ID: 17544870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sibutramine: new preparation. Slight weight loss; but also a slight rise in blood pressure ..
    Prescrire Int; 2001 Oct; 10(55):140-5. PubMed ID: 11824428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study.
    Gaciong Z; Placha G
    J Hum Hypertens; 2005 Sep; 19(9):737-43. PubMed ID: 15905888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.
    James WP; Caterson ID; Coutinho W; Finer N; Van Gaal LF; Maggioni AP; Torp-Pedersen C; Sharma AM; Shepherd GM; Rode RA; Renz CL;
    N Engl J Med; 2010 Sep; 363(10):905-17. PubMed ID: 20818901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of weight reduction by sibutramine on female sexual function.
    Kim KK; Kang HC; Kim SS; Youn BB
    Int J Obes (Lond); 2006 May; 30(5):758-63. PubMed ID: 16404407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials.
    Gu XJ; Chen R; Sun CH; Zheng W; Yang XH; Wang SB; Ungvari GS; Ng CH; Golenkov A; Lok GKI; Li L; Chow IHI; Wang F; Xiang YT
    J Int Med Res; 2018 Jan; 46(1):22-32. PubMed ID: 28718688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.
    Tek C; Ratliff J; Reutenauer E; Ganguli R; O'Malley SS
    J Clin Psychopharmacol; 2014 Oct; 34(5):608-12. PubMed ID: 25102328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Weight gain and antipsychotic drug treatment].
    Patri E; Dantchev N; Martinez M
    Encephale; 2000; 26(6):93-7. PubMed ID: 11217543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An open-label pilot trial of alpha-lipoic acid for weight loss in patients with schizophrenia without diabetes.
    Ratliff JC; Palmese LB; Reutenauer EL; Tek C
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):196-200. PubMed ID: 23471087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Schizophrenia and weight management: a systematic review of interventions to control weight.
    Faulkner G; Soundy AA; Lloyd K
    Acta Psychiatr Scand; 2003 Nov; 108(5):324-32. PubMed ID: 14531752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histamine and antipsychotic drug-induced weight gain.
    Reynolds GP
    J Psychopharmacol; 2012 Dec; 26(12):1608-9. PubMed ID: 23192251
    [No Abstract]   [Full Text] [Related]  

  • 52. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.
    Björkhem-Bergman L; Asplund AB; Lindh JD
    J Psychopharmacol; 2011 Mar; 25(3):299-305. PubMed ID: 20080925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of birth weight and the development of antipsychotic induced adiposity in individuals with treatment resistant schizophrenia.
    Ziauddeen H; Garcia-Rizo C; Bernardo M; Kirkpatrick B; Ozanne SE; Jones PB; Fernandez-Egea E
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):972-8. PubMed ID: 27107738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing self-reported ethnicity and structure-determined ethnicity: analysis of antipsychotic-induced weight gain.
    De Luca V; Monda M; Chan LF
    Pharmacogenomics; 2013 Dec; 14(16):1943. PubMed ID: 24279847
    [No Abstract]   [Full Text] [Related]  

  • 55. A woman who gained weight and became schizophrenic.
    Raj YP
    Lancet; 2003 Feb; 361(9358):704-5; author reply 705. PubMed ID: 12606202
    [No Abstract]   [Full Text] [Related]  

  • 56. Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis.
    Zhuo C; Xu Y; Liu S; Li J; Zheng Q; Gao X; Li S; Jing R; Song X; Yue W; Zhou C; Upthegrove R
    Front Pharmacol; 2018; 9():1393. PubMed ID: 30546312
    [No Abstract]   [Full Text] [Related]  

  • 57. Suicide Attempt in a Patient with Sibutramine Associated Psychosis.
    Câmara Pestana P; Ferreira C; Santos AL; Jerónimo J; Ganança L
    Acta Med Port; 2022 Mar; 35(3):216-218. PubMed ID: 33945464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bionursing: how drugs can cause weight gain.
    Jordan S; Torrance C
    Nurs Stand; 1996 Feb; 10(22):47-50. PubMed ID: 8695453
    [No Abstract]   [Full Text] [Related]  

  • 59. Metformin for antipsychotic-induced weight gain: Statistical curiosities.
    Pinto EF; George B; Karia S; Andrade C
    J Psychopharmacol; 2017 Apr; 31(4):514. PubMed ID: 28347259
    [No Abstract]   [Full Text] [Related]  

  • 60. Adulteration of the Herbal Weight Loss Products by the Illegal Addition of Synthetic Antiobesity Medications: A Pilot Study.
    Firozian F; Nili-Ahmadabadi A; Moradkhani S; Moulaei M; Fasihi Z; Ahmadimoghaddam D
    J Obes; 2021; 2021():9968730. PubMed ID: 34336274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.